PPCP monitoring in the Nordic Countries – Status Report
Hide / Show Abstract

PPCP monitoring in the Nordic Countries – Status Report

The Nordic Screening group is pleased to present a compilation of pharmaceuticals and personal care products (PPCPs) monitoring data from the Nordic countries. The report has been prepared by Bergfald miljørådgivere and founded by the Nordic Council of Ministers via the Aquatic Ecosystems Group and the Nordic Chemicals Group. In recent years, there has been an increased awareness of environmental effects from our use of PPCPs. In order to examine the occurrence of PPCPs in the environment, the Nordic countries have conducted several regional and national environmental surveys. The Nordic screening group saw the need for a compilation of these studies. The objective of this report was therefore to present the existing Nordic environmental data on PPCPs, by identifying which compounds have been analysed, in which countries and if there are obvious variations of levels detected in each country. The Nordic screening is run by a steering group with representatives from the Danish Centre for environment and Energy, Aarhus University, the Finnish Environment Institute, the Environment Agency of Iceland, the Environment Agency of the Faroe Islands, the Norwegian Climate and Pollution Agency and the Swedish Environmental Protection Agency.

Click to Access: 
    http://oecd.metastore.ingenta.com/content/3812311e.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/ppcp-monitoring-in-the-nordic-countries-status-report_tn2012-519
  • READ
 
Chapter
 

Hormones and hormone antagonists You do not have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/3812311ec006.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/ppcp-monitoring-in-the-nordic-countries-status-report/hormones-and-hormone-antagonists_9789289330107-6-en
  • READ
Author(s):
Nordic Council of Ministers

Hide / Show Abstract

This category includes natural and synthetic hormones as well as hormone antagonists. The antagonists are typically active ingredients used in the treatment of prostatic and breast cancer.